Jake coleads McKinsey’s Life Sciences Practice in North America and globally. For more than 15 years, he has guided pharmaceutical and medical-technology company executives on matters of corporate strategy, growth strategy, and operational excellence.
Jake is also one of our longest-standing advisors to the medical-products industry and has helped many of the world’s leading providers of medical devices navigate the rapidly changing value chain. Drawing on a technical background, he appreciates the potential for each new wave of technical advance to have a profound impact on patient care. He also advises private-equity companies seeking healthcare-related mergers and acquisitions.
An expert on changes in US healthcare, Jake speaks frequently at conferences and on professional panels across North America. Most recently, he gave the keynote speech at a meeting of the American Diagnostics Association.
Jake is an active leader in many Chicago civic enterprises. He serves on the boards of both the Civic Consulting Alliance and Choose Chicago, an organization promoting tourism for the city. He is also an active volunteer for the Chicago chapter of Pets Are Worth Saving (PAWS).
Jake is a member of the Duke University Class of 1996 Leadership Giving Committee.
Published work
“Finding the edge: The latest commercial approaches for winning in biopharma and medical products, McKinsey & Company, March 2013
“Capturing value for Dx in personalized medicine—is there a path?,” Personalized Medicine: The path forward, McKinsey & Company, March 2013
Education
Duke University
PhD, mechanical engineering
BEng, mechanical engineering, biomedical engineering